At EHA 2026 this month, Legend Biotech (NASDAQ: LEGN) is presenting early data on LB2501, an in vivo CAR-T therapy that builds CAR-T cells inside…
At EHA 2026 this month, Legend Biotech (NASDAQ: LEGN) is presenting early data on LB2501, an in vivo CAR-T therapy that builds CAR-T cells inside…